Track the 인바이츠바이오코아 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 인바이츠바이오코아 has logged 13 public disclosures. The latest transaction was filed on 16 July 2026 (Sale). Among the most active insiders: 인바이츠지노믹스. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
13 of 13 declarations
InVitesBioCore is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative solutions in the biotechnology field.